Drugs (Pharmaceuticals) – Page 56

Appeals Court Says Abortion Pill Can Remain Available but Imposes Temporary Restrictions

The judges blocked the drug from being sent to patients through the mail and rolled back other steps the government had taken to ease access.

By Pam Belluck

Biotechnology and Bioengineering Decisions and Verdicts Drugs (Pharmaceuticals) Food and Drug Administration Mifeprex (RU-486)

Pfizer CEO and Other Drug Company Leaders Condemn Texas Abortion Pill Ruling

More than 250 executives said that the decision ignored both scientific and legal precedent and, if it stands, would create uncertainty for the pharmaceutical and biotech industries.

By Christina Jewett

Decisions and Verdicts Drugs (Pharmaceuticals) Federal-State Relations (US) Food and Drug Administration mifepristone Regulation and Deregulation of Industry Suits and Litigation (Civil) Supreme Court (US)

Abortion Ruling Could Undermine the F.D.A.’s Drug-Approval Authority

Legal scholars say the ruling by a Texas judge, if upheld, could spur disputes over many medications and upend the drug industry’s reliance on the agency.

By Christina Jewett and Pam Belluck

Bankruptcies Compensation for Damages (Law) Drugs (Pharmaceuticals) Hazardous and Toxic Substances Johnson & Johnson Suits and Litigation (Civil)

Johnson & Johnson Reaches $8.9 Billion Talc Settlement

The company faces a flood of lawsuits claiming its talc products caused cancer. The proposed settlement requires approval by a bankruptcy court, but has the backing of plaintiffs’ lawyers.

By Tiffany Hsu